AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $20,734,000 | +85.8% | 1,526,790 | +3.7% | 0.02% | +58.3% |
| Q1 2020 | $11,161,000 | +7.5% | 1,472,436 | -10.1% | 0.01% | +33.3% |
| Q4 2019 | $10,379,000 | +109.0% | 1,637,081 | +29.2% | 0.01% | +125.0% |
| Q3 2019 | $4,966,000 | -26.1% | 1,266,779 | -8.8% | 0.00% | -33.3% |
| Q2 2019 | $6,720,000 | -34.7% | 1,388,328 | +10.4% | 0.01% | -33.3% |
| Q1 2019 | $10,298,000 | +53.2% | 1,257,336 | +3.4% | 0.01% | +28.6% |
| Q4 2018 | $6,724,000 | -25.1% | 1,215,886 | +19.6% | 0.01% | -12.5% |
| Q3 2018 | $8,976,000 | +897500.0% | 1,016,526 | +787904.7% | 0.01% | – |
| Q2 2018 | $1,000 | – | 129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |